Skip to content
Biodatica
Start free

AstraZeneca

Gainesville, Florida

OncologyPhase IIIListed · AZN

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase I trial registered: Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

2mo agoTrial registeredApr 28, 2026Source filing (opens the source filing in a new tab)

Momentum

77no change

Momentum 77 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE3 registered

    Nov 19, 2021

    Neurofibromatosis 1, Plexiform Neurofibroma (PN) · ACTIVE_NOT_RECRUITING · sponsor: AstraZeneca · Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas

    ClinicalTrials.gov · NCT04924608 (opens the source filing in a new tab)

  2. Trial

    PHASE1 registered

    Oct 6, 2014

    Neoplasms, Myelodysplastic Syndromes, Lymphomas · COMPLETED · sponsor: National Cancer Institute (NCI) · Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

    ClinicalTrials.gov · NCT02211755 (opens the source filing in a new tab)

  3. Trial

    PHASE1 registered

    Jan 25, 2010

    Neoplasms, Lymphoma · COMPLETED · sponsor: National Cancer Institute (NCI) · A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

    ClinicalTrials.gov · NCT01051635 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources